|
1) Hauser WA, Annerger JF, Kurland LT. Prevalence of epilepsy in Rochester, Minnesota: 1940-1980. Epilepsia. 1991; 32: 429-45
|
|
|
|
2) Hauser WA, Annerger JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia. 1993; 34: 453-68
|
|
|
|
|
|
3) Fisher RS, van Emde Boas W, Blume W, et al. Epileptic seizures and epilepsy: definition proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia. 2005; 46: 470-2
|
|
|
|
|
|
4) Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia. 1981; 22: 489-501
|
|
|
|
|
|
5) Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia. 1989; 30: 389-99
|
|
|
|
|
|
6) Engel J. Report of the ILAE Classification core group. Epilepsia. 2006; 47: 1558-68
|
|
|
|
|
|
7) 井上有史. てんかん発作およびてんかんの国際分類の現状. Epilepsy. 2007; 1: 17-22
|
|
|
|
|
|
8) Annegers JF, Hauser WA, Lee JR, et al. Incidence of acute symptomatic seizures in Rochester, Minnesota. 1935-1984. Epilepsia. 1995; 36: 327-33
|
|
|
|
|
|
9) Berg A, Shinnar S. The risk of seizure recurrence following a first unprovoked seizure: a quantitative review. Neurology. 1991; 41: 965-72
|
|
|
|
|
|
10) Hauser WA, Rich SS, Lee JR, et al. Risk of recurrent seizures after two unprovoked seizures. N Eng J Med. 1998; 338: 429-34
|
|
|
|
|
|
11) Shinnar S, Berg AT, O'Dell G, et al. Predictors off multiple seizures in a cohort of children prospectively followed from the time of their first unprovoked seizure. Ann Neurol. 2000; 48: 140-7
|
|
|
|
|
|
12) Pohlmann-Eden B, Beghi E, Camfield C, et al. The first seizure and its management in adults and children. BMJ. 2006; 332: 339-42
|
|
|
|
|
|
13) Marson A, Jacoby A, Johnson A, et al. Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomized controlled trial. Lancet. 2005; 365: 2007-13
|
|
|
|
|
|
14) French JA. Can evidence-based guidelines and clinical trials tell us how to treat patients ？ Epilepsia. 2007; 48: 1264-7
|
|
|
|
|
|
15) Chadwick D, Marson T. Choosing a first drug treatment for epilepsy after SANAD: randomized controlled trials, systematic reviews, guidelines and treating patients. Epilepsia. 2007; 48: 1259-63
|
|
|
|
|
|
16) French JA, Kanner AM, Bautista J, et al. Efficacy and tolerability of the new antiepileptic drugs, I: Treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society. Epilepsia. 2004; 45: 401-9
|
|
|
|
|
|
17) French JA, Kanner AM, Bautista J, et al. Efficacy and tolerability of the new antiepileptic drugs, II: Treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society. Epilepsia. 2004; 45: 410-23
|
|
|
|
|
|
18) Glauser T, Ben-Menachem E, Bourgeois B, et al. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia. 2006; 47: 1094-120
|
|
|
|
|
|
19) Marson AG, Al-Kharusi AM, Alwaidh M, et al. SANAD Study group. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet. 2007; 369: 1016-26
|
|
|
|
|
|
20) Marson AG, Al-Kharusi AM, Alwaidh M, et al. SANAD Study group. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet. 2007; 369: 1000-15
|
|
|
|
|
|
21) Karceski S, Morrel M, Carpenter D. The expert consensus guideline series: treatment of epilepsy. Epilepsy Behav. 2001; 2 (Suppl): A1-50
|
|
|
|
|
|
22) Karceski S, Morrell MJ, Carpenter D. Treatment of epilepsy in adults: expert opinion, 2005. Epilepsy Behav. 2005; 7 Suppl 1: S1-64
|
|
|
|
|
|
23) 井上有史, 西田拓司. てんかん治療のExpert Consensus. てんかん研究. 2004; 22: 128-39
|
|
|
|
|
24) Semah F, Picot MC, Derambure P, et al. The choice of antiepileptic drugs in newly diagnosed epilepsy: a national French survey. Epileptic Disord. 2004; 6: 255-65
|
|
|
|
|
|
25) Wheless JW, Clarke DF, Carpenter D. Treatment of pediatric epilepsy: Expert opinion, 2005. J Child Neurol. 2005; 20: S1-56
|
|
|
|
|
|
26) 日本神経学会治療ガイドライン. てんかん治療ガイドライン. 2002. http://www.neurology-jp.org/guideline/epilepsy/index.htm
|
|
|
|
|
|
27) 日本てんかん学会ガイドライン作成委員会: 成人てんかんにおける薬物治療ガイドライン. てんかん研究. 2005; 23: 249-53. http://square.umin.ac.jp/jes
|
|
|
|
|
|
28) 日本てんかん学会ガイドライン作成委員会: 小児てんかんの包括的治療ガイドライン. てんかん研究. 2005; 23: 244-8. http://square.umin.ac.jp/jes
|
|
|
|
|
|
29) 日本てんかん学会ガイドライン作成委員会: ウエスト症候群の診断・治療ガイドライン. てんかん研究. 2006; 24: 68-73. http://square.umin.ac.jp/jes
|
|
|
|
|
|
30) Stokes T, Shaw EJ, Juarez-Garcia A, et al. Clinical Guidelines and Evidence Review for the Epilepsies: diagnosis and management in adults and children in primary and secondary care. London: Royal College of General Practitioners; 2004
|
|
|
|
|
|
31) Scottish Intercollegiate Guidelines Network. Diagnosis and management of epilepsy. www.sign.ac.uk/pdf/sign70.pd
|
|
|
|
|
|
32) Legros B, Boon P, Dejonghe P, et al. Opinion of Belgian neurologists on antiepileptic drugs: Belgian Study on EpilepsyTreatment (BESET). Acta Neurol Scand. 2007; 115: 97-103
|
|
|
|
|
|
33) Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med. 2000; 342: 314-9
|
|
|
|
|
|
34) Sillanpaa M, Schmidt D. Natural history of treated childhood-onset epilepsy: prospective, long-term population-based study. Brain. 2006; 129: 617-24
|
|
|
|
|
|
35) 日本てんかん学会ガイドライン作成委員会: てんかんをもつ妊娠可能年齢の女性に対する治療ガイドライン. てんかん研究. 2007; 25: 27-31. http://square.umin.ac.jp/jes
|
|
|
|
|
|
36) Berg AT, Shinnar S. Relapse following discontinuation of antiepileptic drugs: a meta-analysis. Neurology. 1994; 44: 601-8
|
|
|
|
|
|
37) Arroyo S, Brodie MJ, Avanzini G, et al. Is refractory epilepsy preventable？ Epilepsia. 2002; 43: 437-44
|
|
|
|
|
|
38) Wiebe S, Blume WT, Girvin JP, et al. A randomized controlled trial of surgery for temporal lobe epilepsy. N Engl J Med. 2001; 345: 311-8
|
|
|
|
|
|
39) 亀山茂樹. 成人てんかんの手術適応. In: 大槻泰介, 三原忠紘, 亀山茂樹, 馬場啓至, 編. 難治性てんかんの外科治療. 東京: 診断と治療社; 2007. p. 32-4
|
|
|
|
|
|
40) 馬場啓至. 小児てんかんの手術適応. In: 大槻泰介, 三原忠紘, 亀山茂樹, 馬場啓至, 編. 難治性てんかんの外科治療. 東京: 診断と治療社; 2007. p. 35-8
|
|
|
|
|